Aging & Geriatrics
Resources
Basic InformationLatest News
Life Span After Alzheimer's Diagnosis: What Factors Matter MostLots of Napping Could Raise a Senior's Odds for Alzheimer'sPfizer Asks FDA to Approve Second Booster for SeniorsIs It 'Pre-Alzheimer's' or Normal Aging? Poll Finds Many Americans UnclearMore Evidence That Exercise Protects the Aging BrainHeaters, Pools, Bed Rails: Household Dangers Can Kill SeniorsUpcoming Surgery Worry You? Poll Says You're Not AloneGood End-of-Life Care Out of Reach for Many Black Nursing Home ResidentsMore Evidence That Education May Protect Against DementiaLifestyle Factors Key to Keeping Good Vision With AgeAHA News: Plant-Based Diet May Slow Cognitive Decline in Black Adults as They AgeStaying Fit May Keep Alzheimer's at BayGetting Active Can Keep Those 'Senior Moments' at BayThese Simple Steps Can Help Seniors Manage Their Health CareHuman Brain Doesn't Slow Down Until After 60Many Who Postponed Health Care During COVID Are Still WaitingIs Sleep Apnea CPAP Useless for Folks Over 80?Apps Can Help Keep Older Folks Healthy — But Most Don't Use ThemClutter in the Attic: Why Memory Falters With AgeWhat You Need to Know About Urinary IncontinenceMacular Degeneration Can Rob You of Sight: Know the SignsMedicare to Provide Free COVID-19 Rapid TestsTake That Walk: Your Aging Brain Will Work BetterShorter Life Spans for Elderly Living Downwind of Fracking Sites: StudyKeeping Weight Stable Could Help Save Your BrainHow Many Steps to Walk Away From Diabetes?Some Patients With Macular Degeneration Could Stop Monthly Eye InjectionsAfter Heart Attack, Cardiac Rehab Begins Road to RecoveryCOVID Boosters Keep Older Americans Out of Hospitals: CDCDo You Feel Old? It Could Be Aging YouCleaner Air Could Mean Healthier Brains for Older WomenFour Factors in Midlife Predict a Healthy Old Age for WomenScientists Work Out How Exercise Saves Your BrainMedicare May Rethink Premium Hike for Pricey Alzheimer’s DrugQuality of Home Health Care Varies Between Urban, Rural AreasMake 2022 Your Year for a Free Memory ScreeningMore U.S. Seniors, Especially Women, Are Retaining Healthy Brains: StudyMore U.S. Women Are Retaining Their Hearing as They AgeOver 60? You Have Billions of Potentially Cancer-Causing CellsMany Seniors on Medicare Falling Into Medical DebtOveractive Bladder, Dangerous Falls Often Go Together for SeniorsCould Viagra Help Prevent Alzheimer's?Black Americans Less Likely to Lose Hearing as They Age'Mild Cognitive Impairment' in Older Age Often Disappears, Study FindsDuring the Holidays, Help Protect the Elderly from Falls'Active Grandparent': Humans Evolved to Exercise in Old AgeReminder Apps on Smartphones May Help in Early DementiaNeurologists' Group Issues Guidance to Families on Controversial Alzheimer's DrugTrial Begins of Nasal Vaccine for Alzheimer's DiseaseGrandmother's Brain In Sync With Her Grandkids': Study
LinksSelf-Help Groups
Related Topics

Depression: Depression & Related Conditions
Elder Care

Pfizer Asks FDA to Approve Second Booster for Seniors


HealthDay News
Updated: Mar 16th 2022

new article illustration

WEDNESDAY, March 16, 2022 (HealthDay News) -- Pfizer Inc. said Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster shot for Americans 65 and older.

In a statement announcing its request, Pfizer relied on data from two studies out of Israel that have been published without peer review on pre-print servers.

The first study, conducted in concert with Israel’s Ministry of Health, reviewed the health records of 1.1 million people and concluded that they were less likely to become infected or develop severe illness after a fourth dose of Pfizer’s vaccine. However, Israel only recently began its second booster program, so it was unclear how long the extra protection might last. Israel began offering fourth doses to health care workers in late December, then quickly broadened eligibility to those 60 and older and other vulnerable groups.

The second study, of Israeli health care workers, showed that while fourth shots of either Pfizer’s or Moderna’s vaccine boosted antibody levels, it was not very effective at preventing infections. Researchers said those findings underscored the urgency of developing vaccines that target whatever variant is circulating.

Still, "both data sets showed evidence that an additional mRNA booster increases immunogenicity and lowers rates of confirmed infections and severe illness," the company said in its statement.

Pfizer CEO Dr. Albert Bourla has said more than once in the past week that the company believes a fourth shot will be needed to counter the waning power of the third shot.

A meeting of an FDA expert advisory committee to discuss the issue of second booster shots is expected to be held next month, The New York Times reported.

While a fourth shot for all older Americans without weakened immune systems may be a good idea now, giving extra booster shots to the general population should probably be put on hold until the fall, some senior Biden administration officials suggest.

“Barring any surprises from new variants, maybe the best thing is to think about our booster strategy in conjunction with the influenza vaccine next fall, and get as many people as possible boosted then," Dr. Peter Marks, the FDA's top vaccine regulator, told the Times last month.

Any recommendation on a second booster shot would likely target people most at risk, possibly based on underlying conditions as well as age, Dr. Anthony Fauci, chief medical adviser to the White House, has said.

In addition, the administration is running short on funds for COVID vaccines, a senior White House official told reporters on condition of anonymity Tuesday, the Times reported. The official said there is enough money to cover fourth shots for people with weakened immune systems, but additional funding from Congress would be needed to pay for second boosters for all Americans.

A U.S. Centers for Disease Control and Prevention study released last month showed that protection began to weaken after a booster shot of either the Pfizer or Moderna vaccine, but it did not analyze cases by age, immune deficiencies or underlying health conditions.

More information

Visit the U.S. Food and Drug Administration for more on COVID boosters.


SOURCE: The New York Times



328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net